CanSino Biologics Inc.
COVID-19 Vaccine Developer CanSinoBIO Seeks To Raise $743m In STAR IPO
Business - Published date: .
CanSino Biologics Inc (CanSinoBIO), a Chinese biopharmaceutical company that is developing a COVID-19 vaccine candidate... Read more
Hong Kong Biotech Firms Seek Listings On Chinas Star Board
Business - Published date: .
CanSino Biologics Inc. is joining other Hong Kong-listed biotechnology companies in seeking to list on Shanghai’s Sta... Read more